26 results on '"West, Michael L."'
Search Results
2. Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
3. Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease.
4. Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry.
5. Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
6. The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process.
7. Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report.
8. Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report.
9. Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report.
10. Cardiomyopathy and kidney function in agalsidase beta‐treated female Fabry patients: a pre‐treatment vs. post‐treatment analysis.
11. Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism.
12. Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report.
13. Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis.
14. Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction.
15. Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.
16. Tetrahydrobiopterin deficiency in the pathogenesis of Fabry disease.
17. Uncertain Diagnosis of Fabry Disease in Patients with Neuropathic Pain, Angiokeratoma or Cornea Verticillata: Consensus on the Approach to Diagnosis and Follow-Up.
18. Gender-specific plasma proteomic biomarkers in patients with Anderson-Fabry disease.
19. Gender-specific plasma proteomic biomarkers in patients with Anderson-Fabry disease.
20. A modification of the urine osmolal gap: an improved method for estimating urine ammonium.
21. A renal mechanism limiting the degree of potassium loss in severely hyperglycemic patients.
22. Renal potassium handling during states of low aldosterone bio-activity: a method to differentiate renal and non-renal causes.
23. Possible Role of the Intestinal P‐450 Enzyme System in a Cyclosporine‐Clarithromycin Interaction.
24. Dde as a Protecting Group for Carbohydrate Synthesis.
25. Solid-Phase Oligosaccharide Chemistry and Its Application to Library Synthesis.
26. BRONCHIOLITIS OBLITERANS AND ORGANIZING PNEUMONIA IN RENAL TRANSPLANT RECIPIENTS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.